DNTH · Dianthus Therapeutics, Inc. /DE/
Market Cap
$5.92B
Shares
55.93M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-06-12 | — | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-09 | 2026-05-21 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-12 | 2026-03-10 | |
| 8-K | 2026-03-09 | — | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-16 | — | |
| 8-K | 2025-09-11 | 2025-09-09 | |
| 8-K | 2025-09-08 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-05-22 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-10 | 2025-05-22 | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-03-11 | — | |
| 8-K | 2025-03-05 | 2025-03-04 | |
| 8-K | 2024-12-12 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-16 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-05-28 | 2024-05-23 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-11 | 2024-05-23 | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-01-22 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-21 | — | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-10-25 | 2023-10-19 | |
| 8-K/A | 2023-09-21 | 2023-09-11 | |
| 8-K | 2023-09-12 | 2023-09-11 | |
| 8-K | 2023-09-08 | — |
Showing 1–50 of 110 filings
Key facts
CIK
1690585
CUSIP
252828108
13F (30d)
244 filings
241 filers
Visit website
Investor relations